Endoscopic vacuum-assisted closure therapy for leakage of the lower gastrointestinal tract: multicenter experiences
- PMID: 36845275
- PMCID: PMC9949981
- DOI: 10.1055/a-1990-0392
Endoscopic vacuum-assisted closure therapy for leakage of the lower gastrointestinal tract: multicenter experiences
Abstract
Background and study aims Only a few studies are available regarding endoscopic vacuum-assisted closure (E-VAC) therapy for the post-surgery leakage of the lower gastrointestinal tract. Patients and methods In this multicenter German study, we retrospectively analyzed patients treated with E-VAC therapy due to post-surgery leakage of the lower gastrointestinal tract from 2000-2020 at Hannover Medical School, University Medical Center Schleswig-Holstein, Campus Luebeck, and Robert Koch Hospital Gehrden. Results Overall, 147 patients were included in this study. Most patients had undergone tumor resections of the lower gastrointestinal tract (n = 88; 59.9 %). Median time to diagnosis of leakage was 10 days (interquartile range [IQR] 6-19). Median duration of E-VAC therapy was 14 days (IQR 8-27). Increase of C-reactive protein (CRP) levels significantly correlated with first diagnosis of leakage ( P < 0.001). E-VAC therapy led to closure or complete epithelialization of leakage in the majority of patients (n = 122; 83.0 %) and stoma reversal was achieved in 60.0 %. Stoma reversal was significantly more often achieved in patients with CRP levels ≤ 100 mg/L at first diagnosis compared to patients with CRP levels > 100 mg/L (78.4 % vs. 52.7 %; P = 0.012). Odds ratio for failure of stoma reversal was 3.36 in cases with CRP values > 100 mg/L ( P = 0.017). In total, leakage- and/ or E-VAC therapy-associated complications occurred in 26 patients (17.7 %). Minor complications included recurrent E-VAC dislocations and subsequent stenosis. Overall, 14 leakage- or E-VAC-associated deaths were observed most often due to sepsis. Conclusions E-VAC therapy due to post-surgery leakage of the lower gastrointestinal tract is safe and effective. High levels of CRP are a negative predictor of E-VAC therapy success.
The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Conflict of interest statement
Competing interests The authors declare that they have no conflict of interest.
Figures



Similar articles
-
Endoscopic vacuum assisted closure (E-VAC) of upper gastrointestinal leakages.Scand J Gastroenterol. 2021 Nov;56(11):1376-1379. doi: 10.1080/00365521.2021.1963836. Epub 2021 Aug 21. Scand J Gastroenterol. 2021. PMID: 34420453
-
Endoscopic Vacuum-Assisted Closure Therapy in Patients with Anastomotic Leakage after Esophagectomy: A Single-Center Experience.Gastroenterol Res Pract. 2018 Apr 4;2018:1697968. doi: 10.1155/2018/1697968. eCollection 2018. Gastroenterol Res Pract. 2018. PMID: 29849581 Free PMC article.
-
Results of endoscopic vacuum-assisted closure device for treatment of upper GI leaks.Surg Endosc. 2018 Apr;32(4):1906-1914. doi: 10.1007/s00464-017-5883-4. Epub 2017 Dec 7. Surg Endosc. 2018. PMID: 29218673
-
Endoluminal vacuum-assisted closure (E-Vac) therapy for postoperative esophageal fistula: successful case series and literature review.World J Surg Oncol. 2020 Nov 14;18(1):301. doi: 10.1186/s12957-020-02073-6. World J Surg Oncol. 2020. PMID: 33189152 Free PMC article. Review.
-
Vacuum-assisted closure versus closure without vacuum assistance for preventing surgical site infections and infections of chronic wounds: a meta-analysis of randomized controlled trials.Surg Infect (Larchmt). 2014 Aug;15(4):363-7. doi: 10.1089/sur.2013.028. Epub 2014 May 8. Surg Infect (Larchmt). 2014. PMID: 24810943 Review.
Cited by
-
Pull-through endoscopic vacuum-assisted closure therapy for complicated leaks of the gastrointestinal tract: Novel technique.Endosc Int Open. 2025 Jan 30;13:a24200499. doi: 10.1055/a-2420-0499. eCollection 2025. Endosc Int Open. 2025. PMID: 39958666 Free PMC article.
References
-
- Lee W S, Yun S H, Roh Y N et al.Risk factors and clinical outcome for anastomotic leakage after total mesorectal excision for rectal cancer. World J Surg. 2008;32:1124–1129. - PubMed
-
- Glitsch A, von Bernstorff W, Seltrecht U et al.Endoscopic transanal vacuum-assisted rectal drainage (ETVARD): an optimized therapy for major leaks from extraperitoneal rectal anastomoses. Endoscopy. 2008;40:192–199. - PubMed
-
- Nagell C F, Holte K. Treatment of anastomotic leakage after rectal resection with transrectal vacuum-assisted drainage (VAC). A method for rapid control of pelvic sepsis and healing. Int J Colorectal Dis. 2006;21:657–660. - PubMed
-
- Jimenez-Rodriguez R M, Araujo-Miguez A, Sobrino-Rodriguez S et al.A new perspective on vacuum-assisted closure for the treatment of anastomotic leak following low anterior resection for rectal cancer: Is it worthy? Surg Innov. 2018;25:350–356. - PubMed
-
- Weidenhagen R, Gruetzner K U, Wiecken T et al.Endoscopic vacuum-assisted closure of anastomotic leakage following anterior resection of the rectum: a new method. Surg Endosc. 2008;22:1818–1825. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous